{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:06:42Z","timestamp":1789006002613,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"GSK\/BLF Chair of Respiratory Research"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.arbres.2018.10.012","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T12:52:27Z","timestamp":1554900747000},"page":"286-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bronchiectasis Guidelines-Recommendations Into Practice"],"prefix":"10.1016","volume":"55","author":[{"given":"Margarida","family":"Redondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2018.10.012_bib0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00221-2018","article-title":"New era for European Respiratory Society clinical practice guidelines: joining efficiency and high methodological standards","volume":"51","author":"Miravitlles","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0090","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01987-2017","article-title":"Macrolides, mucoactive drugs and adherence for the management of bronchiectasis","volume":"51","author":"Guan","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jebm.12018","article-title":"Understanding GRADE: an introduction","volume":"6","author":"Goldet","year":"2013","journal-title":"J Evid Based Med."},{"key":"10.1016\/j.arbres.2018.10.012_bib0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Munoz","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1 a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2 a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/13993003.00232-2016","article-title":"Quality standards for the management of bronchiectasis in Italy: a national audit","volume":"48","author":"Aliberti","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01289-2017","article-title":"Standardised classification of the aetiology of bronchiectasis using an objective algorithm","volume":"50","author":"Araujo","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2010.142778","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax."},{"key":"10.1016\/j.arbres.2018.10.012_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbr.2017.07.013","article-title":"Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults","volume":"54","author":"Martinez-Garcia","year":"2018","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2018.10.012_bib0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbr.2017.07.014","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Martinez-Garcia","year":"2018","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2018.10.012_bib0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5694\/mjac14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust."},{"key":"10.1016\/j.arbres.2018.10.012_bib0080","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02444-2017","article-title":"RESPIRE: breathing new life into bronchiectasis","volume":"51","author":"Chotirmall","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2018.10.012_bib0085","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"Araujo","year":"2018","journal-title":"Eur Respir J."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618304101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618304101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T11:03:44Z","timestamp":1560423824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289618304101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0300289618304101"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2018.10.012","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis Guidelines-Recommendations Into Practice","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2018.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}